Erector Spinae Plane Block for Analgesia During ESWL

NCT ID: NCT07067996

Last Updated: 2025-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-13

Study Completion Date

2025-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this study aims to compare between efficacy of erector spinae plane block and conventional multimodal analgesia in Extracorporeal shock wave lithotripsy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Stone

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A : will receive Erector Spinae Plane Block in the prone position after URS.

* Patients in the block group (Group A)will receive the ESPB in the prone position after URS. ESPB needle insertion sites will be tolerated to the location of the stone, between T7-T10 vertebra levels. With these adjustments, Following the marking of the thoracic vertebrae levels with a marker pen,
* The intervention will be initiated when the transverse processes and costotransverse joints on the relevant level will be distinguished using a high frequency(10-15 MHZ) linear ultrasound probe. The needle will be inserted at a 30° angle to the skin in an in-plane and craniocaudal fashion
* Proper placement will be confirmed with ultrasonography and then 20 mL of 0.25% bupivacaine solution\&5 ml lidocaine 1% will be administered through the needle for intraoperative and postoperative anaglesia.

Group Type ACTIVE_COMPARATOR

erector spinae plane block

Intervention Type PROCEDURE

erector spinae plane block will be given as intraoperive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

group B : will receive nalbuphine

•(Group B) patients will receive opioids ,nalbuphine( ,1 )mg/kg over 10 minutes then repeat the dose if needed \&monitoring patients for respiratory depression

Group Type ACTIVE_COMPARATOR

Nalbuphine

Intervention Type DRUG

Nalbuphine will be given as intraopertive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

erector spinae plane block

erector spinae plane block will be given as intraoperive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

Intervention Type PROCEDURE

Nalbuphine

Nalbuphine will be given as intraopertive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult Patients undergoing ESWL with 2-3 cm renal stones
* patients between the ages of 21 and 60,
* both sexes,
* BMI ≥18≤30 kg/m²
* Able to give informed consent.
* Patients older than 18 years with American Society of Anesthesiologists Physical Status I or II and

Exclusion Criteria

* Coagulopathy or on anticoagulants
* Infection at the ESPB injection site
* BMI ≥30 kg/m²
* Patient refusal.
* patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
* patients with a history of allergies to any study drugs
Minimum Eligible Age

21 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amr Abdelsabor

Resident, Anesthesia,Sugical Icu,Pain management Faculty of Medicine Sohag Univesity

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag University Hospital

Sohag, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amr A Abdelaziz, resident

Role: CONTACT

01112942400

Khaled M Hassan, professor

Role: CONTACT

01144357827

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Magdy M Amin, professor

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Karaaslan M, Olcucuoglu E, Kurtbeyoglu S, Tonyali S, Yilmaz M, Odabas O. Erector spinae plane block prior to extracorporeal shock wave lithotripsy decreases fluoroscopy time and promise a comfortable procedure for renal stones: A prospective randomized study. Actas Urol Esp (Engl Ed). 2023 Nov;47(9):566-572. doi: 10.1016/j.acuroe.2023.04.001. Epub 2023 Apr 20. English, Spanish.

Reference Type RESULT
PMID: 37084807 (View on PubMed)

Yayik AM, Ahiskalioglu A, Erguney OD, Oral Ahiskalioglu E, Alici H, Demirdogen SO, Adanur S. Analgesic efficacy of ultrasound-guided quadratus lumborum block during extracorporeal shock wave lithotripsy. Agri. 2020 Jan;32(1):44-47. doi: 10.5505/agri.2017.54036.

Reference Type RESULT
PMID: 32030700 (View on PubMed)

Alhashemi JA, Kaki AM. Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy. Can J Anaesth. 2004 Apr;51(4):342-7. doi: 10.1007/BF03018237.

Reference Type RESULT
PMID: 15064262 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med--25-6-8MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment of Upper Ureteric Stones
NCT02469766 UNKNOWN PHASE4
Energy Ramping Versus Fixed Dose ESWL
NCT07334236 NOT_YET_RECRUITING NA